FOXO4-DRI represents a transformative breakthrough in senescence research that has fundamentally changed our understanding of cellular aging and opened unprecedented opportunities for studying age-related diseases and interventions
Journal of Physiology (Paris), 1993, 87(5):313-327
Preclinical Observations Findings observed in murine studies include: Endurance capacity: Increased treadmill running time and distance Mitochondrial function: Enhanced respiration and ATP production in muscle Cardiac metabolism: Improved fatty acid utilization in models of heart failure Renal function: Reduced mitochondrial dysfunction and inflammation in aging kidney models Metabolic profile: Improved glucose handling in metabolic syndrome models These results are limited to animal models using intraperitoneal injection
Best for: Patients whose hair loss followed a period of illness, scalp inflammation, surgery, or significant physical stress
peptide therapy stands for Body Protection Compound 157, and its derived from a naturally occurring protein in the stomach
Premium-grade Peptide available in lyophilized form.
